本页面由Tiger Trade Technology Pte. Ltd.提供服务

Theravance Biopharma Inc.

17.03
0.0000
成交量:- -
成交额:- -
市值:8.83亿
市盈率:16.30
高:17.03
开:17.03
低:17.03
收:17.03
52周最高:21.03
52周最低:13.08
股本:5,182.83万
流通股本:2,585.69万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):1.05
每股收益(LYR):2.06
净资产收益率:20.91%
总资产收益率:1.33%
市净率:3.05
市盈率(LYR):8.27

数据加载中...

2022/02/23

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/10

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/12/16

重要事件披露

8-K - Current report
2021/12/06

重要事件披露

8-K/A [Amend] - Current report
2021/11/16

重要事件披露

8-K - Current report
2021/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/03

重要事件披露

8-K - Current report
2021/10/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/05

重要事件披露

8-K/A [Amend] - Current report
2021/09/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/15

重要事件披露

8-K - Current report
2021/09/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/23

重要事件披露

8-K - Current report